Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
25.0 mg/kg/injection |
83.0 |
Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
50.0 mg/kg/injection |
104.0 |
Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
100.0 mg/kg/injection |
99.0 |
Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
200.0 mg/kg/injection |
102.0 |
Antitumor endpoint evaluated on day 20; 10/10 animals surviving on day 20 |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
400.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 20; 01/10 animals surviving on day 20 |
Q07DX002 (ip) |
median tumor weight (est.) |
saline with Tween-80 |
800.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 20; 00/10 animals surviving on day 20 |